PortfoliosLab logoPortfoliosLab logo
ARKG vs. ARKY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ARKG vs. ARKY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK 21Shares Active Bitcoin Ethereum Strategy ETF (ARKY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ARKG

1D
-0.24%
1M
10.92%
YTD
17.09%
6M
10.02%
1Y
53.35%
3Y*
0.67%
5Y*
-15.72%
10Y*
7.22%

ARKY

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. ARKY - Yearly Performance Comparison


Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARKG vs. ARKY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG
ARKG Risk / Return Rank: 3535
Overall Rank
ARKG Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3737
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3232
Omega Ratio Rank
ARKG Calmar Ratio Rank: 3838
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3131
Martin Ratio Rank

ARKY
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. ARKY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK 21Shares Active Bitcoin Ethereum Strategy ETF (ARKY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARKGARKYDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.22

Calmar ratioReturn relative to maximum drawdown

1.95

Martin ratioReturn relative to average drawdown

4.67

ARKG vs. ARKY - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


ARKGARKYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.31

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

0.13

Drawdowns

ARKG vs. ARKY - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than ARKY's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for ARKG and ARKY.


Loading charts...

Drawdown Indicators


ARKGARKYDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

0.00%

-83.59%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

Current Drawdown

Current decline from peak

-69.65%

0.00%

-69.65%

Average Drawdown

Average peak-to-trough decline

-35.87%

0.00%

-35.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.46%

Volatility

ARKG vs. ARKY - Volatility Comparison


Loading charts...

Volatility by Period


ARKGARKYDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.90%

Volatility (6M)

Calculated over the trailing 6-month period

28.77%

Volatility (1Y)

Calculated over the trailing 1-year period

41.12%

0.00%

+41.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.61%

0.00%

+45.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.12%

0.00%

+41.12%

ARKG vs. ARKY - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is lower than ARKY's 1.00% expense ratio.


Dividends

ARKG vs. ARKY - Dividend Comparison

Neither ARKG nor ARKY has paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
ARKY
ARK 21Shares Active Bitcoin Ethereum Strategy ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


On fees, ARKG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

ARKG is cheaper with a 0.75% expense ratio, compared with 1.00% for ARKY.

ARKG and ARKY have nearly identical dividend yields, around 0.00%.

ARKG is categorized as Health & Biotech Equities, while ARKY is Cryptocurrency. Their fees differ too: 0.75% for ARKG and 1.00% for ARKY.

Portfolio Optimizer

Find the right allocation for ARKG and ARKY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer